BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 28117600)

  • 1. Sodium Chloride Enhances Recombinant Adeno-Associated Virus Production in a Serum-Free Suspension Manufacturing Platform Using the Herpes Simplex Virus System.
    Adamson-Small L; Potter M; Byrne BJ; Clément N
    Hum Gene Ther Methods; 2017 Feb; 28(1):1-14. PubMed ID: 28117600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scalable recombinant adeno-associated virus production using recombinant herpes simplex virus type 1 coinfection of suspension-adapted mammalian cells.
    Thomas DL; Wang L; Niamke J; Liu J; Kang W; Scotti MM; Ye GJ; Veres G; Knop DR
    Hum Gene Ther; 2009 Aug; 20(8):861-70. PubMed ID: 19419276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector.
    Grieger JC; Soltys SM; Samulski RJ
    Mol Ther; 2016 Feb; 24(2):287-297. PubMed ID: 26437810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An efficient rHSV-based complementation system for the production of multiple rAAV vector serotypes.
    Kang W; Wang L; Harrell H; Liu J; Thomas DL; Mayfield TL; Scotti MM; Ye GJ; Veres G; Knop DR
    Gene Ther; 2009 Feb; 16(2):229-39. PubMed ID: 18923452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
    Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus clearance during purification of a recombinant adeno-associated virus serotype 1 vector.
    Ye GJ; Scotti MM; Thomas DL; Wang L; Knop DR; Chulay JD
    Hum Gene Ther Clin Dev; 2014 Dec; 25(4):212-7. PubMed ID: 25357151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells.
    Durocher Y; Pham PL; St-Laurent G; Jacob D; Cass B; Chahal P; Lau CJ; Nalbantoglu J; Kamen A
    J Virol Methods; 2007 Sep; 144(1-2):32-40. PubMed ID: 17467815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids.
    Booth MJ; Mistry A; Li X; Thrasher A; Coffin RS
    Gene Ther; 2004 May; 11(10):829-37. PubMed ID: 14985784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioreactor production of recombinant herpes simplex virus vectors.
    Knop DR; Harrell H
    Biotechnol Prog; 2007; 23(3):715-21. PubMed ID: 17461549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical evaluation of a recombinant adeno-associated virus vector expressing human alpha-1 antitrypsin made using a recombinant herpes simplex virus production method.
    Chulay JD; Ye GJ; Thomas DL; Knop DR; Benson JM; Hutt JA; Wang G; Humphries M; Flotte TR
    Hum Gene Ther; 2011 Feb; 22(2):155-65. PubMed ID: 20812844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detailed Protocol for the Novel and Scalable Viral Vector Upstream Process for AAV Gene Therapy Manufacturing.
    Selvaraj N; Wang CK; Bowser B; Broadt T; Shaban S; Burns J; Saptharishi N; Pechan P; Golebiowski D; Alimardanov A; Yang N; Mitra G; Vepachedu R
    Hum Gene Ther; 2021 Aug; 32(15-16):850-861. PubMed ID: 33397196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-yield recombinant adeno-associated viral vector production by multivariate optimization of bioprocess and transfection conditions.
    Coplan L; Zhang Z; Ragone N; Reeves J; Rodriguez A; Shevade A; Bak H; Tustian AD
    Biotechnol Prog; 2024; 40(3):e3445. PubMed ID: 38450973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: from shake flasks to a 20-L bioreactor.
    Meghrous J; Aucoin MG; Jacob D; Chahal PS; Arcand N; Kamen AA
    Biotechnol Prog; 2005; 21(1):154-60. PubMed ID: 15903253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of recombinant adeno-associated virus production using an herpes simplex virus amplicon system.
    Feudner E; de Alwis M; Thrasher AJ; Ali RR; Fauser S
    J Virol Methods; 2001 Aug; 96(2):97-105. PubMed ID: 11445141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving adeno-associated vector yield in high density insect cell cultures.
    Mena JA; Aucoin MG; Montes J; Chahal PS; Kamen AA
    J Gene Med; 2010 Feb; 12(2):157-67. PubMed ID: 20101623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clearance and characterization of residual HSV DNA in recombinant adeno-associated virus produced by an HSV complementation system.
    Ye GJ; Scotti MM; Liu J; Wang L; Knop DR; Veres G
    Gene Ther; 2011 Feb; 18(2):135-44. PubMed ID: 20668485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transduction of striatum and cortex tissues by adeno-associated viral vectors produced by herpes simplex virus- and baculovirus-based methods.
    Zhang HS; Kim E; Lee S; Ahn IS; Jang JH
    J Virol Methods; 2012 Jan; 179(1):276-80. PubMed ID: 22015677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and purification of recombinant adeno-associated vectors.
    Wang L; Blouin V; Brument N; Bello-Roufai M; Francois A
    Methods Mol Biol; 2011; 807():361-404. PubMed ID: 22034039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Popularizing Recombinant Baculovirus-derived OneBac System for Laboratory Production of all Recombinant Adeno-associated Virus Vector Serotypes.
    Wu Y; Han Z; Duan M; Jiang L; Tian T; Jin D; Wang Q; Xu F
    Curr Gene Ther; 2021; 21(2):167-176. PubMed ID: 33461466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilizing minimally purified secreted rAAV for rapid and cost-effective manipulation of gene expression in the CNS.
    Goodwin MS; Croft CL; Futch HS; Ryu D; Ceballos-Diaz C; Liu X; Paterno G; Mejia C; Deng D; Menezes K; Londono L; Arjona K; Parianos M; Truong V; Rostonics E; Hernandez A; Boye SL; Boye SE; Levites Y; Cruz PE; Golde TE
    Mol Neurodegener; 2020 Mar; 15(1):15. PubMed ID: 32122372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.